Quantcast
More

    Melbourne: Footballer Jackson Williams cleared of sexual assault after dragging nurse down a laneway

    Footballer who dragged a nurse down a laneway before off-duty cop pulled him off her is CLEARED of sexual assault after judge decided 'he...

    Jeffrey Toobin walks his dog after Zoom masturbation ordeal

    EXCLUSIVE: Jeffrey Toobin is pictured walking his dog under cover of darkness a day after it was revealed he was was caught masturbating on...

    Arabella Del Busso flaunts underboob in X-rated selfie

    Notorious former WAG Arabella Del Busso flaunts her toned abs and a generous glimpse of underboob in a skimpy white crop topBy Alisha Buaya...

    Warning over toxic trendy pink salt as it’s revealed some brands have dangerous levels of LEAD

    Warning over toxic trendy pink salt as it's revealed some brands have dangerous levels of LEAD and heavy metals - while white salt is...

    Coronavirus: Remdesivir has ‘little effect’ on death risks, says WHO

    BREAKING NEWS: Remdesivir has ‘little effect’ on COVID-19 death risks, WHO study study finds

    • The antiviral remdesivir is one of just two COVID-19 treatments that has emergency FDA approval in the US 
    • A WHO trial of 11,266 hospitalized COVID-19 patients tested remdesivir, hydroxychloroquine, lopinavir and interferon treatments 
    • The SOLIDARITY trial found that none of the four ‘substantially affected’ mortality rates 

    Remdesivir does not improve COVID-19 survival odds, a large World Health Organization (WHO) trial of it and three other treatments has ruled.

    More than 11,200 hospitalized COVI-19 patients around the world were treated with remdesivir – an antiviral – lopinavir, hydroxychloroquine, interferon or a placebo for the WHO’s massive SOLIDARITY trial. 

    None of the drugs ‘substantially affected’ mortality risks, the dismal report found. 

    It’s a blow to hopes that the world is getting better at treating people sickened by the pandemic that has claimed the lives of more than a million people globally, including more than 217,000 in the US. 

    SOLIDARITY’s findings are particularly grim news for the US, where remdesivir is one of just two treatments to have gotten emergency Food and Drug Administration (FDA) authorization. 

    US government research suggested the drug improved survival odds and shortened recovery times.  

    The federal government has already amassed a stockpile of the drug, and regulators revoked emergency approval for another drug found ineffective for treating coronavirus by the WHO trial, hydroxychloroquine, in June. 

    This is a developing story.  

    A massive WHO study found that remdesivir had no significant effect on COVID-19 death risks

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Posts

    Trump’s Campaign Cash Dwindled to $63 Million Entering October

    President Trump’s re-election campaign committee ended September with only $63.1 million in the bank despite canceling some television buys late last month, leaving him...

    Candice Warner refuses to answer questions about her feud with Roxy Jacenko

    Candice Warner refuses to answer questions about her feud with former friend Roxy Jacenko as she steps out in Sydney following their dramatic falling...

    You can now buy $5 GINGERBREAD ice cream for the festive season

    You can now buy $5 GINGERBREAD ice cream for the festive season - complete with spiced biscuits and a sweet caramel ripple Coles has launched...

    Chloe Madeley shows off her toned figure in black lingerie for photoshoot

    Chloe Madeley shows off her toned figure in black lingerie for photoshoot as she hits out at those who think she 'built a career...